Stay updated on Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:46:59.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.4%
    Check dated 2025-06-06T09:26:04.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T00:16:59.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.6%
    Check dated 2025-05-22T21:52:27.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-15T19:49:09.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page has updated its date information, adding new dates for events in 2025 and 2026 while removing some earlier dates in 2025.
    Difference
    0.6%
    Check dated 2025-05-08T13:06:47.000Z thumbnail image

Stay in the know with updates to Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.